⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANVS News
Annovis Bio, Inc.
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
globenewswire.com
ANVS
ANTARES VISION GROUP MÉTAMORPHOSE LA SUPPLY CHAIN AGROALIMENTAIRE EN UN ÉCOSYSTÈME NUMÉRIQUE AU CFIA 2026
prnewswire.com
ANVS
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
globenewswire.com
ANVS
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
globenewswire.com
ANVS
Annovis to Host Corporate Update Webinar on January 28, 2026
globenewswire.com
ANVS
Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group
globenewswire.com
ANVS
Annovis Announces Two Presentations at the CTAD 2025 Conference
globenewswire.com
ANVS
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
globenewswire.com
ANVS
Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients
globenewswire.com
ANVS
Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results
globenewswire.com
ANVS